![]() Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | ||
Founding Date | Founding Date 2001 | Founding Date 1896 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Gent, BE HQ | |
Employees | Employees 1252% decrease | Employees 103,249 |
Financial | ||
Revenue (est.) | Revenue (est.) €85.2m (FY, 2016) | Revenue (est.) CHF61.5b (FY, 2025) |
Net income | Net income (€1.1m) (FY, 2016) | Net income CHF13.8b (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 498.8m | Total funding raised $ 7.8b |

Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
View company